PCVAX | SSGSX | PCVAX / SSGSX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 28 years | 26 years | - |
Gain YTD | -1.587 | 0.431 | -368% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 2500 | 2500 | 100% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 284M | 6.33B | 4% |
Annual Yield % from dividends | 2.15 | 0.35 | 605% |
Returns for 1 year | 5.15 | -1.03 | -500% |
Returns for 3 years | -13.33 | -3.55 | 376% |
Returns for 5 years | -11.10 | 6.73 | -165% |
Returns for 10 years | -50.65 | 21.22 | -239% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
JEVIX | 9.30 | 0.05 | +0.54% |
JHancock Disciplined Value Em Mkts Eq I | |||
JIECX | 18.62 | -0.11 | -0.59% |
JPMorgan International Equity C | |||
RYCRX | 32.90 | -0.36 | -1.08% |
Rydex Real Estate C | |||
AVLVX | 14.51 | -0.30 | -2.03% |
Avantis U.S. Large Cap Value Inst | |||
LVOFX | 19.35 | -0.48 | -2.42% |
Lord Abbett Value Opportunities F |